GGT1 and breast cancer: Based on these premises, we tested a hypothesis that GGT1 gene SNPs might affect the level of GGT protein in tissues and serum, which would, in turn, affect the efficacy and toxicity of neoadjuvant chemotherapy in breast cancer.